Patent Expiry
Patent/Exclusivity Expiry: ERMEZA
- Drug
- ERMEZA
Other upcoming events for MAIA
Phase 3 ReadoutPhase 3 Topline: A Multicenter, Open-label, Randomized Phase 3 Study of THIO Sequenced With Cemiplimab (LIBTAYO®) vs
Patent ExpiryPatent/Exclusivity Expiry: CUBICIN
Patent ExpiryPatent/Exclusivity Expiry: THYQUIDITY
Patent ExpiryPatent/Exclusivity Expiry: OLPRUVA
Patent ExpiryPatent/Exclusivity Expiry: LEVOTHYROXINE SODIUM
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.